OpenMETU
metadata only
Machine learning-based drug response prediction in colorectal cancer with reduced features
artificial-intelligencebioinformaticsbiotechnologycolorectal-cancercomputational-biologycomputer-sciencesengineering-and-technologylife-sciences
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Machine learning to develop and validate a model for predicting the risk of lymph node metastasis in colorectal cancer patients.#430807
- Multi-omics feature engineering driven by biomedical foundation models improves drug response prediction for inflammatory bowel disease patients.#148392
- Machine Learning Models for Predicting Liver Metastasis at Diagnosis and Overall Survival in Ovarian Cancer: A SEER-Based Study.#244278
- Diagnosis, Treatment, and Prevention of Colorectal Cancer Amid Abnormal Lipid Metabolism#810134
- Treatment-aware deep learning enables counterfactual prediction of individual benefit from PARP inhibitors in ovarian cancer#374393
Record · ID 686250
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive